#USA #New York #Class Action #Geron Corporation #GERN

Important Notice for Geron Corporation Shareholders

The Gross Law Firm has recently issued a critical notification aimed at shareholders of Geron Corporation (NASDAQ: GERN). This communication is particularly relevant for individuals who acquired shares of GERN during the specified class period from February 28, 2024, to February 25, 2025.

Understanding the Class Action Allegations

The allegations in this case stem from concerns that the firm's executives provided misleading information regarding the growth potential of their drug, Rytelo (imetelstat). Investors were informed about an optimistic outlook for the launch and trajectory of Rytelo, which purportedly addressed a significant unmet medical need. However, the firm allegedly downplayed the risks associated with the treatment, including complications related to weekly monitoring and the competitive landscape of existing therapies.

On February 26, 2025, Geron announced its financial results for the fourth quarter of the fiscal year 2024, revealing a concerning stagnation in Rytelo’s sales growth. This news came as a shock to investors as it was attributed to seasonality, increased competition, insufficient awareness about Rytelo, and the burdensome requirements for patient monitoring. Following this announcement, Geron's stock plummeted dramatically from $2.37 per share to a mere $1.61 per share within a day—a stark decline of approximately 32.07%.

Deadline for Shareholders

The impending deadline for shareholders wishing to take part in the class action is May 12, 2025. All shareholders who purchased shares during the specified period are encouraged to register without delay. By registering, shareholders can secure their position in the class action and stay informed about the case’s developments through a dedicated portfolio monitoring service.

It is crucial to note that registration is free of charge and does not obligate shareholders to serve as lead plaintiffs. Being appointed as a lead plaintiff is not a prerequisite to participate in any potential recovery efforts related to the lawsuit.

Next Steps for Shareholders

To register for this class action and protect your rights as an investor, you can visit the Gross Law Firm’s dedicated webpage. Upon registration, you will receive status updates throughout the legal process, ensuring that you remain well-informed regarding your investment's status.

The Gross Law Firm stands as a nationally recognized class action law firm with a commitment to safeguarding investor rights. Their mission revolves around holding companies accountable for misleading practices that result in financial loss for stakeholders. They have a robust track record of pursuing recovery for investors affected by unethical business conduct.

For any inquiries or to initiate the registration process, you can contact The Gross Law Firm directly.

Contact Information:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Email: info@grosslawfirm.com
• - Phone: (646) 453-8903

Take swift action to safeguard your rights as a shareholder of Geron Corporation. The deadline is approaching rapidly, and every moment counts in ensuring your voice is heard in this class action lawsuit.